CDS

Sprott Inc. Declares First Quarter 2024 Dividend

Retrieved on: 
Martedì, Maggio 7, 2024
Depository Trust Company, Cede and Company, SII, CDS, Holding company

TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (“Sprott” or the “Company”) (NYSE/TSX: SII) announced today that its Board of Directors has declared a first quarter 2024 dividend of US$0.25 per common share, payable on June 5, 2024 to shareholders of record at the close of business on May 21, 2024.

Key Points: 
  • TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (“Sprott” or the “Company”) (NYSE/TSX: SII) announced today that its Board of Directors has declared a first quarter 2024 dividend of US$0.25 per common share, payable on June 5, 2024 to shareholders of record at the close of business on May 21, 2024.
  • However, beneficial holders whose intermediary is a participant in CDS, may elect to change the currency of their dividend payments to U.S. dollars and can contact their broker for more details.
  • Registered shareholders, other than CDS, who are residents of Canada and wish to receive their dividend in U.S. dollars should make arrangements to deposit their common shares with CDS, and make a currency election, prior to May 21, 2024.
  • The dividend is designated as an eligible dividend for Canadian income tax purposes.

ICE Clear Credit Adds Royal Bank of Canada as a Clearing Member

Retrieved on: 
Giovedì, Maggio 9, 2024
Data Analytics, Finance, Asset Management, Banking, Data Management, Professional Services, Technology, Fintech, Credit, Ecosystem, ICE Clear Credit, RBC, Royal Bank of Canada, ICE, MD, Intercontinental Exchange, CDS, Intercontinental, Credit derivative, Index

Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of technology and data, today announced that Royal Bank of Canada (RBC), Canada’s largest bank by capitalization and designated as one of the global systemically important banks, has become a clearing member at ICE Clear Credit LLC, the leading global clearinghouse for credit default swaps.

Key Points: 
  • Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of technology and data, today announced that Royal Bank of Canada (RBC), Canada’s largest bank by capitalization and designated as one of the global systemically important banks, has become a clearing member at ICE Clear Credit LLC, the leading global clearinghouse for credit default swaps.
  • ICE Clear Credit provides a comprehensive product offering, robust mark-to-market services and state-of-the-art risk management approach.
  • “RBC is one of the largest banks in North America and globally, and we’re very pleased to have them join ICE Clear Credit as a clearing member,” said Stan Ivanov, President of ICE Clear Credit.
  • For more information about ICE Clear Credit, please visit: https://www.ice.com/clear-credit .

Nutrien Declares Quarterly Dividend of US$0.54 per Share

Retrieved on: 
Mercoledì, Maggio 8, 2024
Agriculture, Natural Resources, NTR, TSX, Bank, Depository Trust Company, Cede and Company, Income Tax Act, CDS, Security (finance)

Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024.

Key Points: 
  • Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024.
  • However, registered shareholders of Nutrien may elect to change the currency of their dividend payments to US dollars or Canadian dollars, as applicable.
  • In addition, Nutrien offers registered shareholders direct deposit by electronic funds transfer for dividend payments.
  • All dividends paid by Nutrien are, pursuant to subsection 89(14) of the Income Tax Act (Canada), designated as eligible dividends.

Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument

Retrieved on: 
Mercoledì, Maggio 8, 2024
ACT, C-peptide, Chromatography software, Mass, Analytic, Research, LC-MS, Waters Corporation, API, Food, CDS, Mass spectrometry, WAT

MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations. This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution. It enhances and complements Waters best-in-class ACQUITY Premier Liquid Chromatography (LC) separations portfolio to enable flexible analysis of both small and large molecules across pharmaceutical, food, chemical, and materials applications.

Key Points: 
  • MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations.
  • This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution.
  • The ACQUITY QDa II Mass Detector is designed to seamlessly integrate into existing laboratory workflows with the usability and format of a LC detector.
  • The ACQUITY QDa II Mass Detector is designed for compliance-ready deployment on Waters Empower™ Chromatography Data System (CDS) Software.

Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument

Retrieved on: 
Mercoledì, Maggio 8, 2024
ACT, C-peptide, Chromatography software, Mass, Analytic, Research, LC-MS, Waters Corporation, API, Food, CDS, Mass spectrometry, WAT, Fine chemical

MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations. This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution. It enhances and complements Waters best-in-class ACQUITY Premier Liquid Chromatography (LC) separations portfolio to enable flexible analysis of both small and large molecules across pharmaceutical, food, chemical, and materials applications.

Key Points: 
  • MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations.
  • This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution.
  • The ACQUITY QDa II Mass Detector is designed to seamlessly integrate into existing laboratory workflows with the usability and format of a LC detector.
  • The ACQUITY QDa II Mass Detector is designed for compliance-ready deployment on Waters Empower™ Chromatography Data System (CDS) Software.

Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting

Retrieved on: 
Lunedì, Aprile 22, 2024
Corneal opacity, AAV2, Nanopore, Rabbit, Immortalised cell line, Genomics, LTR, CRISPR, Genetic engineering, Abraxis BioScience, Infection, Gene, RNA, Recurrence, HeLa, Paratriathlon, Cell, HSK, AAV, Vero cell, Research, Pterygopalatine ganglion, FACS, PCR, Disease, DNA, Therapy, Viral load, HIV-1, Society, CDS, Gag, ICP0, Genome, Herpes simplex keratitis, LAT, Orientation, Annual general meeting, Edema, Valaciclovir, SAN, Vaccine

Herpes Simplex Keratitis (HSK), caused by the infection of herpes simplex virus type 1 (HSV-1) in the cornea, is a major cause of blindness worldwide.

Key Points: 
  • Herpes Simplex Keratitis (HSK), caused by the infection of herpes simplex virus type 1 (HSV-1) in the cornea, is a major cause of blindness worldwide.
  • Although current anti-HSV-1 therapies interfere with viral DNA replication, they do not eliminate HSV-1 reservoirs or prevent recurrence.
  • CRISPR/Cas-mediated gene editing can potentially address the underlying causes of the disease by directly eliminating the latent HSV-1 reservoirs.
  • The 440 guide RNA pairs formed with these 42 PlmCasX guide RNAs were tested in tissue culture for DNA excision efficiency.

Turning Point Brands Announces First Quarter 2024 Results

Retrieved on: 
Giovedì, Maggio 2, 2024
Online Retail, Retail, Tobacco, Specialty, Convenience Store, MST, FDA, Clipper, Zigzag, Webcast, Growth, CDS, EPS, FRE, Adjustment, TPB, Wrap (food), ID, GAAP

(“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today financial results for the first quarter ended March 31, 2024.

Key Points: 
  • (“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today financial results for the first quarter ended March 31, 2024.
  • For the quarter, the Zig-Zag Products segment gross profit increased 23.0% to $27.5 million.
  • For the first quarter, CDS net sales were $14.0 million, gross profit was $3.6 million, and gross margin was 25.4%.
  • As previously disclosed, a conference call with the investment community to review TPB’s financial results has been scheduled for 10:00 a.m. Eastern on Thursday, May 2, 2024.

Crucial Data Solutions Introduces TrialKit PACS to Streamline Image Management in Clinical Trials

Retrieved on: 
Martedì, Aprile 23, 2024
Research, Technology, Clinical Trials, Health Technology, Software, Biotechnology, Internet, Health, Data Management, Science, Radiology, DICOM, DDC, EHR, EDC, ChromeOS, PHI, PACS, CDS, Data collection, MRI, Clinical trial, Control, Medical imaging

Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS .

Key Points: 
  • Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS .
  • This innovative solution streamlines medical image management within clinical trials, offering a unified platform for all data collection and management needs.
  • TrialKit PACS streamlines medical image capture into EDC trials by eliminating the time and cost of third party systems licensing and integration.
  • Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative data collection and clinical trial management technology on the market today.

WASTE CONNECTIONS ANNOUNCES REGULAR QUARTERLY CASH DIVIDEND

Retrieved on: 
Mercoledì, Aprile 24, 2024
WCN, Waste Connections, DTC, Bank, Computershare, CDS

TORONTO, April 24, 2024 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.285 U.S. per common share of the Company.

Key Points: 
  • TORONTO, April 24, 2024 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.285 U.S. per common share of the Company.
  • The regular quarterly cash dividend will be paid on May 23, 2024 to shareholders of record at the close of business on May 8, 2024.
  • The Board intends to review the quarterly dividend each October, with a long-term objective of increasing the amount of the dividend.
  • Shareholders of Waste Connections whose common shares are held by a bank or broker that participates in U.S. depositary DTC will receive payment of their dividends in U.S. dollars.

FDB Targeted Medication Warnings™ Earns Epic Toolbox Designation

Retrieved on: 
Martedì, Aprile 23, 2024
Health Level 7, Hospital, FHIR, EHR, Software, Epic Systems, API, Toolbox, SMART, Medication, Patient safety, FDB, Patient, CDS, Health, First Databank, Pharmacist, SAN, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., April 23, 2024 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that its FDB Targeted Medication Warnings™ solution has earned the new Toolbox designation from Epic Systems Corporation in the Medication Dosing Decision Support Toolbox category.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., April 23, 2024 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that its FDB Targeted Medication Warnings™ solution has earned the new Toolbox designation from Epic Systems Corporation in the Medication Dosing Decision Support Toolbox category.
  • FDB Targeted Medication Warnings is part of the FDB PatientFirst™ suite of clinical decision support (CDS) solutions.
  • Several factors supported Targeted Medication Warnings' Toolbox designation, including its recently announced integration with CDS Hooks *.
  • Epic customers who want to learn more about how they can enhance efficiency for clinicians while improving patient safety and quality of patient care through advanced patient-specific medication decision support can find FDB Targeted Medication Warnings at vendorservices.epic.com/Showroom/Listing?id=851.